Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...
Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...
Eli Lilly And Co. (NYSE:LLY) is ramping up its legal campaign against the compounding companies temporarily allowed to make ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Rival manufacturers fight for the right to sell weight loss drugsThere’s a new fight brewing between ...
If you or someone you know has diabetes, you’ve likely heard of metformin, a drug that’s primarily prescribed to support ...